Bionano Genomics, Inc. (BNGO)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 52.88M |
| Enterprise Value | 30.40M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.82 |
| Price/Book (mrq) | 0.55 |
| Enterprise Value/Revenue | 0.84 |
| Enterprise Value/EBITDA | -0.14 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 2.37 |
| 52-Week Change 3 | -88.40% |
| S&P500 52-Week Change 3 | 21.83% |
| 52 Week High 3 | 9.0000 |
| 52 Week Low 3 | 0.8500 |
| 50-Day Moving Average 3 | 1.1170 |
| 200-Day Moving Average 3 | 2.4209 |
Share Statistics
| Avg Vol (3 month) 3 | 1.62M |
| Avg Vol (10 day) 3 | 2.1M |
| Shares Outstanding 5 | 61.23M |
| Implied Shares Outstanding 6 | 69.31M |
| Float 8 | 54.49M |
| % Held by Insiders 1 | 0.50% |
| % Held by Institutions 1 | 11.91% |
| Shares Short (Mar 28, 2024) 4 | 5.27M |
| Short Ratio (Mar 28, 2024) 4 | 3.69 |
| Short % of Float (Mar 28, 2024) 4 | 9.67% |
| Short % of Shares Outstanding (Mar 28, 2024) 4 | 9.64% |
| Shares Short (prior month Feb 29, 2024) 4 | 5.23M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:10 |
| Last Split Date 3 | Aug 07, 2023 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -269.97% |
Management Effectiveness
| Return on Assets (ttm) | -33.39% |
| Return on Equity (ttm) | -134.56% |
Income Statement
| Revenue (ttm) | 36.12M |
| Revenue Per Share (ttm) | 1.06 |
| Quarterly Revenue Growth (yoy) | 30.50% |
| Gross Profit (ttm) | N/A |
| EBITDA | -125.72M |
| Net Income Avi to Common (ttm) | -232.49M |
| Diluted EPS (ttm) | -6.8100 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 66.77M |
| Total Cash Per Share (mrq) | 1.22 |
| Total Debt (mrq) | 79.41M |
| Total Debt/Equity (mrq) | 82.59% |
| Current Ratio (mrq) | 1.40 |
| Book Value Per Share (mrq) | 2.10 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -125.18M |
| Levered Free Cash Flow (ttm) | -97.73M |
© 2024 Yahoo. All rights reserved.